Multi-morbidity as a Definable Antiaging Target
Regulators such as the FDA do not consider aging to be a disease, and they only approve treatments for specific diseases, largely using the World Health Organization’s International Classification of Diseases as the basis for what is and is not a disease. The TAME (Targeting Aging with Metformin) trial came into being as a way
Regulators such as the FDA do not consider aging to be a disease, and they only approve treatments for specific diseases, largely using the World Health Organization’s International Classification of Diseases as the basis for what is and is not a disease. The TAME (Targeting Aging with Metformin) trial came into being as a way …
Read More
About Author
